Prosecution Insights
Last updated: April 19, 2026
Application No. 18/038,526

SYSTEMS AND DEVICES FOR CARDIAC ARRHYTHMIA THERAPIES

Non-Final OA §102
Filed
May 24, 2023
Examiner
LEVICKY, WILLIAM J
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Maxwell Biomedical Inc.
OA Round
1 (Non-Final)
69%
Grant Probability
Favorable
1-2
OA Rounds
3y 5m
To Grant
98%
With Interview

Examiner Intelligence

Grants 69% — above average
69%
Career Allow Rate
397 granted / 572 resolved
-0.6% vs TC avg
Strong +29% interview lift
Without
With
+29.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
56 currently pending
Career history
628
Total Applications
across all art units

Statute-Specific Performance

§101
7.8%
-32.2% vs TC avg
§103
38.1%
-1.9% vs TC avg
§102
21.2%
-18.8% vs TC avg
§112
24.3%
-15.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 572 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Efimov et al (US Publication 2011/0009916). Referring to Claim 1, Efimov et al teaches a system for treating cardiac arrhythmias (e.g. Paragraph [0061] discloses terminating arrhythmias), the system comprising: a generator (e.g. Figure 19A, Element 506) including: a sensing circuitry configured to evaluate one or more identified signals representative of electrical activity of the heart and detect a tachyarrhythmia (e.g. Figure 19A, Element 512 and Paragraphs [0027] and [0079]); a control circuitry that is configured to control delivery of a therapy in response to the detected arrhythmia (e.g. Figure 19A, Element 516 and Paragraph [0110] discloses control circuitry 516, in response to the atrial arrhythmia, controls generation and selective delivery of therapy), the therapy including: a first state of electrical pulses delivered via at least a first electrode, wherein the first set of electrical pulses is configured to destabilize and/or terminate a reentry associated with the arrhythmia (e.g. Figure 10, Element 400 and Paragraph [0103]); a first lead coupled to the generator, wherein the first lead includes the first electrode (e.g. Figure 1A, electrode 11 and Figure 19A, electrodes 502 or 504). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to William J Levicky whose telephone number is (571)270-3983. The examiner can normally be reached Monday-Thursday 8AM-5PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Hamaoui can be reached at (571)270-5625. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /WILLIAM J LEVICKY/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

May 24, 2023
Application Filed
Jun 12, 2025
Non-Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12589241
Dual Sensor Electrodes for Providing Enhanced Resuscitation Feedback
2y 5m to grant Granted Mar 31, 2026
Patent 12569690
CARDIAC CONTRACTILITY MODULATION FOR ATRIAL ARRHYTHMIA PATIENTS
2y 5m to grant Granted Mar 10, 2026
Patent 12569686
CHRONICALLY IMPLANTABLE SYSTEMS AND METHODS FOR AFFECTING CARDIAC CONTRACTILITY AND/OR RELAXATION
2y 5m to grant Granted Mar 10, 2026
Patent 12558557
DISCRIMINATION OF SUPRAVENTRICULAR TACHYCARDIAS IN COMBINED CCM-ICD DEVICE
2y 5m to grant Granted Feb 24, 2026
Patent 12544580
DETACHABLE LEADLESS PACEMAKER SYSTEM FOR CARDIAC CONDUCTION BUNDLE PACING
2y 5m to grant Granted Feb 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
69%
Grant Probability
98%
With Interview (+29.1%)
3y 5m
Median Time to Grant
Low
PTA Risk
Based on 572 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month